In the authors' words
“This research will provide the first insight into the efficacy of LCn-3s alone or in combination with exercise in breast cancer survivors with regards to LBM and quality of life.”
What was measured
About the study
- Type
- Other
- Who took part
- Midlife women, breast cancer survivors
- How many
- 153
- How long
- 24 weeks
- Exercise
- Aerobic plus resistance, Exercise with supplements
- Cited
- 12 times, per Europe PMC
- PubMed ID
- 24739260
How to read this. Each line is one study, summarised in plain language from its PubMed abstract, with the authors' own sentence underneath on the study page. A count of studies is not a verdict: trials differ in size, length and quality, and a result in one group of women may not hold in another. Nothing here is medical advice.
Summaries are generated, then checked by machine against the abstract they came from; any summary that could not be matched word for word was left out. Our clinical lead is reviewing the summaries topic by topic, and this note will change when that is done. Corpus last refreshed 2026-11-03. Spotted a mistake? Tell us and we will fix the summary or remove the study.
Similar studies
- A meta-analysis of 32 studies in postmenopausal women found aerobic, resistance and combined exercise training reduced inflammatory markers IL-6, TNF-alpha and CRP, and increased adiponectin, versus control.
- A meta-analysis of 101 trials with 5,697 postmenopausal women found aerobic training reduced fat mass and resistance training increased muscle mass, with combined training offering both benefits.
- A meta-analysis of 4 trials in 256 postmenopausal women with osteoporosis or osteopenia found exercise programmes improved physical function, pain, role physical and vitality quality-of-life domains.
- A review of seven trials with 400 women found exercise therapies showed very uncertain or little effect on joint pain, stiffness, grip strength or quality of life from aromatase inhibitor side effects.